[HTML][HTML] Targeting cancer stemness in the clinic: from hype to hope
Tumors are composed of non-homogeneous cell populations exhibiting varying degrees of
genetic and functional heterogeneity. Cancer stem cells (CSCs) are capable of sustaining …
genetic and functional heterogeneity. Cancer stem cells (CSCs) are capable of sustaining …
[HTML][HTML] Cancer stem cell heterogeneity: origin and new perspectives on CSC targeting
Most of the cancers are still incurable human diseases. According to recent findings,
especially targeting cancer stem cells (CSCs) is the most promising therapeutic strategy …
especially targeting cancer stem cells (CSCs) is the most promising therapeutic strategy …
Cancer stem cell hypothesis for therapeutic innovation in clinical oncology? Taking the root out, not chopping the leaf
K Dzobo, DA Senthebane, A Rowe… - Omics: a journal of …, 2016 - liebertpub.com
Clinical oncology is in need of therapeutic innovation. New hypotheses and concepts for
translation of basic research to novel diagnostics and therapeutics are called for. In this …
translation of basic research to novel diagnostics and therapeutics are called for. In this …
Cancer stem cells
Cancer stem cells (CSCs) are a small subpopulation of cells within tumors with capabilities
of self-renewal, differentiation, and tumorigenicity when transplanted into an animal host. A …
of self-renewal, differentiation, and tumorigenicity when transplanted into an animal host. A …
[HTML][HTML] Stem cell programs in cancer initiation, progression, and therapy resistance
Over the past few decades, substantial evidence has convincingly revealed the existence of
cancer stem cells (CSCs) as a minor subpopulation in cancers, contributing to an aberrantly …
cancer stem cells (CSCs) as a minor subpopulation in cancers, contributing to an aberrantly …
Advances in cancer stem cell targeting: How to strike the evil at its root
BM Pützer, M Solanki, O Herchenröder - Advanced drug delivery reviews, 2017 - Elsevier
Cancer progression to metastatic stages is still unmanageable and the promise of effective
anti-metastatic therapy remains largely unmet, emphasizing the need to develop novel …
anti-metastatic therapy remains largely unmet, emphasizing the need to develop novel …
Cancer stem cells: perspectives for therapeutic targeting
C Maccalli, R De Maria - Cancer immunology, immunotherapy, 2015 - Springer
Cells with “stemness” and tumor-initiating properties have been isolated from both
hematological and solid tumors. These cells denominated as cancer stem cells (CSCs) …
hematological and solid tumors. These cells denominated as cancer stem cells (CSCs) …
[HTML][HTML] Cancer stem cells—key players in tumor relapse
M Marzagalli, F Fontana, M Raimondi, P Limonta - Cancers, 2021 - mdpi.com
Simple Summary Cancer is one of the hardest pathologies to fight, being one of the main
causes of death worldwide despite the constant development of novel therapeutic strategies …
causes of death worldwide despite the constant development of novel therapeutic strategies …
Cancer stem cells: an insight into the development of metastatic tumors and therapy resistance
The term “cancer stem cells”(CSCs) refers to cancer cells that exhibit traits parallel to normal
stem cells, namely the potential to give rise to every type of cell identified in a tumor …
stem cells, namely the potential to give rise to every type of cell identified in a tumor …
[HTML][HTML] Tumour stem cell-targeted treatment: elimination or differentiation
A wide range of studies suggest that most cancers are clonal and may represent the
progeny of a single cell, a cancer stem cell (CSC) endowed with the capacity to maintain …
progeny of a single cell, a cancer stem cell (CSC) endowed with the capacity to maintain …